Discover
Stocks
Healthcare
JAZZ
JAZZ
Jazz Pharmaceuticals
133.82
-0.29
(
-0.22%
)
Market Open
Delayed Prices By NASDAQ,
in USD
Trade
Buy
JAZZ
Jazz Pharmaceuticals
Overview
Chart
Analysis
News
Stats
Trade
Buy
FINANCIAL SUMMARY
For the fiscal year ended 31/12/2022: Jazz Pharmaceuticals's revenues increased by 18.26% and amounted to 3.66B. Net income increased by 32.03% to -224.06M. Net assets decreased by 22.18% to 3.09B and EPS increased from -5.52 to -3.58.
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Gross Margin
Net Profit Margin
Operating Margin
Return On Investment